X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
1st-line therapy (1) 1
aged (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
bevacizumab - administration & dosage (1) 1
cancer patients (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
care and treatment (1) 1
chemotherapy (1) 1
critical care medicine (1) 1
development and progression (1) 1
disease-free survival (1) 1
dosage and administration (1) 1
erbb receptors - genetics (1) 1
erlotinib (1) 1
erlotinib hydrochloride - administration & dosage (1) 1
eurtac trial (1) 1
female (1) 1
gefitinib (1) 1
gene mutations (1) 1
genetic aspects (1) 1
growth-factor receptor (1) 1
health aspects (1) 1
humans (1) 1
ii trial (1) 1
index medicus (1) 1
intention to treat analysis (1) 1
international cooperation (1) 1
lung cancer, non-small cell (1) 1
lung neoplasms - drug therapy (1) 1
lung neoplasms - genetics (1) 1
male (1) 1
middle aged (1) 1
mutation (1) 1
open-label (1) 1
proof of concept study (1) 1
pulmonary/respiratory (1) 1
research (1) 1
respiratory system (1) 1
response evaluation criteria in solid tumors (1) 1
survival (1) 1
t790m mutation (1) 1
tumor-growth (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 5, pp. 435 - 444
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.